Ischemia and no obstructive coronary arteries (INOCA): A narrative review
Author:
Publisher
Elsevier BV
Subject
Cardiology and Cardiovascular Medicine
Reference189 articles.
1. Ischemia and No obstructive coronary artery disease (INOCA): developing evidence-based therapies and Research agenda for the next decade;Bairey Merz;Circulation,2017
2. Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events;Jespersen;Eur. Heart J.,2012
3. Prevalence and prognosis of nonobstructive coronary artery disease in patients undergoing coronary angiography or coronary computed tomography angiography: a meta-analysis;Wang;Mayo Clin. Proc.,2017
4. Nonobstructive coronary artery disease and risk of myocardial infarction;Maddox;JAMA,2014
5. Coronary microvascular reactivity to adenosine predicts adverse outcome in women evaluated for suspected ischemia results from the National Heart, Lung and Blood Institute WISE (Women's Ischemia Syndrome Evaluation) study;Pepine;J. Am. Coll. Cardiol.,2010
Cited by 36 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Higher fasting glucose is associated with poorer survival in non-diabetic subjects having ischemia with non-obstructive coronary arteries;Scientific Reports;2024-09-05
2. Association Between Systemic Inflammation Response Index and Slow Coronary Flow Phenomenon in Patients with Ischemia and No Obstructive Coronary Arteries;International Journal of General Medicine;2024-09
3. Coronary Microvascular Disease Registry (CMDR): Study design and rationale;Cardiovascular Revascularization Medicine;2024-09
4. Patients With Non-Obstructive Coronary Artery Disease and Polyvascular Disease. Sub-Analysis of the Real-World Registry KAMMA (Clinical Registry on Patient Population With Polyvascular Disease in the Russian Federation and Eurasian Countries);Kardiologiia;2024-08-31
5. Generation of a medicine food homology formula and its likely mechanism in treatment of microvascular angina;Frontiers in Pharmacology;2024-08-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3